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Abstract
Mammalian S100B protein plays multiple important roles in cellular brain processes. The
protein is a clinically used marker for several pathologies including brain injury, neurodegen-
eration and cancer. High levels of S100B released by astrocytes in Down syndrome
patients are responsible for reduced neurogenesis of neural progenitor cells and induction
of cell death in neurons. Despite increasing understanding of S100B biology, there are still
many questions concerning the detailed molecular mechanisms that determine specific
activities of S100B. Elevated overexpression of S100B protein is often synchronized with
increased nitric oxide-related activity. In this work we show S100B is a target of exogenous
S-nitrosylation in rat brain protein lysate and identify endogenous S-nitrosylation of S100B
in a cellular model of astrocytes. Biochemical studies are presented indicating S-nitrosyla-
tion tunes the conformation of S100B and modulates its Ca2+ and Zn2+ binding properties.
Our in vitro results suggest that the possibility of endogenous S-nitrosylation should be
taken into account in the further studies of in vivo S100B protein activity, especially under
conditions of increased NO-related activity.
Introduction
Mammalian S100B protein is an important player in a variety of cellular processes. Its biologi-
cal activity is exhibited through intracellular and extracellular interactions with many different
protein targets and has been a subject of extensive studies for over the last 30 years [1]. Intracel-
lularly, a direct role of protein—S100B interactions has been proven for example in the dynam-
ics of cytoskeleton assembly, activity of transcription factors, calcium homeostasis, and cell
proliferation and differentiation [1–3]. Extracellular roles for S100B include its interaction with
cell surface proteins leading to either neurotrophic or neurotoxic effects depending on the con-
centration of the protein [4]. S100B is expressed in a variety of cells, the most in brain tissue by
astrocytes, oligodendrocytes and Schwann cells but also in melanocytes, myofibers, enteric glial
cells, adipocytes, chondrocytes and other (for a comprehensive review see ref. [5–7]). Elevated
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S100B levels have been detected in brains of patients with Alzheimer disease, Creutzfeld-Jacobs
disease, schizophrenia, brain tumors and epilepsy [8–10]. Recently, strong expression and
release of S100B has been shown for astroglia obtained from human induced pluripotent stem
cells derived from Down Syndrome (DS) patients and related with reduced neurogenesis and
increased neuronal cell death [11]. Elevated S100B level is a clinically used diagnostic bio-
marker for several brain pathologies and melanoma [12–14]. Its contribution to cancer pro-
gression, mediated through interaction with the cellular tumor antigen p53, is the basis for
increasingly successful, structure based, rational drug design for melanoma treatment [12].
Although the knowledge on the biology of S100B is rapidly increasing, the mechanistic details
of its regulation have not been fully elucidated. Metal ion binding and the role of cysteine resi-
dues are the two factors mainly discussed in literature that influence the biological activity of
S100B. Acetylation of the protein amino terminus is the only detected post translational modi-
fication of S100B with unknown function [15].
Ca2+ ion is one of the best characterized regulators of S100B activity. There are two pairs of
Ca2+-binding EF-hand motifs in a homodimer of S100B. One pair of EF-hands consists of a 12
amino acid long C-terminal motif and a second N-terminal site build of 14 amino acids, which
is observed only in S100 proteins. Binding of Ca2+ induces a conformational rearrangement of
the protein [2, 16]. The hydrophobic, helical C-terminal part exposed upon Ca2+ binding is
one of the sites of interaction with a large number of S100B targets. Ambiguously, Ca2+ associa-
tion constants measured for S100B at physiological ionic strength are in the range of 103 M-1
which is too small to explain any biologically relevant Ca2+- dependent interactions at the Ca2+
concentration in vivo [17, 18]. Some factors that increase Ca2+ binding to S100B have been
already identified in vitro such as complex formation with target peptides or covalent derivati-
zation of the cysteine thiols with mercaptoethanol or fluorescence markers [19].
Interactions of S100B with some important targets, e.g. tau protein, may be modulated by
Zn2+ instead of Ca2+ ion binding [20, 21]. An S100B dimer coordinates at least two Zn2+ ions
with a much higher affinity than it binds Ca2+ [22, 23]. Despite an initial hypothesis based on
impaired Zn2+ binding to the Cys84Ala mutant of S100B, the cysteine thiol group is not
involved in Zn2+ binding to the protein [21]. Instead, the Zn2+-binding sites observed in a crys-
tal structure of a Ca2+ and Zn2+ loaded S100B were formed at the interface of the protein
homodimer by a combination of histidine and carboxylate side chains originating from both
S100B subunits [21]. Thus, the strongly decreased Zn2+ affinity of Cys84Ala mutant could not
be easily explained.
Other roles for cysteine residues of S100B protein have also been suggested. For example,
activity of S100B as a neurite extension factor (NEF) was lost when either of the two S100B cys-
teines was altered by site-directed mutagenesis [24, 25]. Although micromolar concentrations
of S100B Cys68ValCys84Ser mutant were able to stimulate glial activation, the 83 stop mutant
that did not contain Cys84, was significantly less effective [25]. The important role of cysteines
in S100B lead to a hypothesis, which has not yet been properly proven, of the in vivo formation
of a covalent disulfide S100B dimer.
Development of redox proteomics technologies has shown that cysteines in proteins have
very different reactivities. They not only form disulfide bridges but also are targets of modifica-
tions by various redox reactive species which are produced in cells during normal function, but
may also serve as sensitive, reversible switches in response to different stimuli [26, 27].
Interestingly, in many pathophysiological conditions the high overexpression of S100B pro-
tein is synchronized with significantly increased nitric oxide-related activity [28–30]. A rele-
vant physiological consequence of in vivo nitric oxide synthases expression and NO
production is S-nitrosylation (SNO) of protein cysteine thiols [31, 32]. Elevated nitric oxide
synthase activity induces elevated levels of protein S-nitrosylation (protein SNO) [33]. Protein
S-Nitrosylated Astrocytic S100B Protein
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SNO is a reversible posttranslational modification (PTM) which has been shown to regulate
signal transduction in diverse tissues including brain [34–36]. Thousands of proteins have
been recently identified as SNO targets using proteomic methods [37–40]. Aberrant protein
SNO has been documented in human pathologies, e.g. neurodegeneration or cancer [34, 36].
Formation of protein SNO relies on nitric oxide production and other factors including the
enzymatic activity of nitrosylating and denitrosylating proteins, redox status of the cell and
some still unclear elements defining the susceptibility of a specific protein cysteine to S-nitrosy-
lation [41, 42]. Thus far, there are no reliable methods to theoretically predict sites of posttrans-
lational SNO in proteins, such as those developed for other types of PTM's and only
experimental methods are used to predict the susceptibility of a protein cysteine towards this
modification.
In our previous work we have revealed that Cys84 in recombinant S100B and Cys85 in
another S100 protein family member, recombinant S100A1, are S-nitrosylated in a Ca2+-
dependent manner by S-nitrosoglutathione (GSNO)—a low-molecular weight endogenous
nitrosothiol [43]. Furthermore, we have reported that the Cys85 of S100A1 protein is an
endogenous target of S-nitrosylation in PC12 cells [44]. Comparison of structural NMR data
for unmodified S100A1SH and S100A1SNO found that the modified Cys85 thiol side chain is
involved in a thiol/aromatic molecular switch which changes the conformation and Ca2+ ion
affinity of S100A1. Based on these results and the sequence similarity of S100 proteins we have
proposed that S-nitrosylation may be a regulatory mechanism for a subgroup of S100 proteins
with a conserved cysteine residue in their functionally important C-terminal helix.
Recombinant S100BSNO produced by us previously has been shown by van Dieck et al. to
modify S100B interaction with peptide fragments of tumor suppressor p53. Nitrosylation
increased S100B binding to the p53 C-terminus, but did not affect the second site of interac-
tion—the N-terminal p53 transactivation domain [45].
The goal of this work was to testify whether S100B is susceptible to S-nitrosylation in in
vitro experimental models of higher biological complexity including cells. This would be an
important prediction of the potential biological relevance of S100B S-nitrosylation in vivo. The
successful detection of S100BSNO inside cells has prompted us to characterize the possible
consequences of S-nitrosylation on the properties of S100B protein including metal-binding,
which are best known to modulate its interactions with targets. We show that S-nitrosylation
of Cys84 increases S100B proteins affinity toward Ca2+ and Zn2+ ions. Additionally, data are
presented based on a non-classical structure elucidation method–the measurement of proton-
deuterium exchange rates by mass spectrometry (HDex-MS) that imply that SNO formation
fine-tunes the conformation of S100B protein in a metal-free state. Our results suggest that the
possibility of endogenous S-nitrosylation should be taken into account in the further studies of
in vivo S100B protein activity, especially under conditions of increased NO-related activity.
Materials and Methods
Animals
The study included wild-type adult male Wistar rats (3 months old) obtained from the Animal
House of Polish Academy of Sciences Medical Research Center. All experimental procedures
were performed and carried out in accordance with Polish guidelines for care and use of labo-
ratory animals. All animals were housed in the same facility that maintained a 12:12 h light-
dark cycle temperatures between 20–26°C, and humidity between 30–70%. In each indepen-
dent experiment (n = 3), one adult male Wistar rat was sacrificed by decapitation under isoflur-
ane anesthesia and the brain was rapidly removed and kept in HEN buffer (see below) on ice.
The experimental protocols were approved by the Local Ethical Committee on Animal
S-Nitrosylated Astrocytic S100B Protein
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Experiments of the Nencki Institute (Permit Number 454/2013) and all efforts were made to
minimize animal suffering and to decrease the number of animal used.
Cell culture experiments
Rat C6 glioma cells (ATCC) were a kind gift of Prof. Jacek Kuznicki (IIMCB, Warsaw, Poland).
Cells were cultured at 37°C in a humidified atmosphere containing 5% CO2, in DMEM
medium (Gibco) with 10% fetal bovine serum (Gibco), 100 U/ml penicillin (Gibco), and 100
U/ml streptomycin (Gibco). Prior analysis intact cells were thoroughly washed with PBS and
cultured for additional 24 hours in DMEMmedium with only 1% FBS.
Analysis of exogenous S-nitrosylation in rat brain tissue
Freshly isolated rat brain was homogenized in 10 volumes of HEN buffer (25 mMHEPES pH
7.7, 1 mM EDTA, and 10 μM neocuproine) and centrifuged at 20,000 x g for 15 min at 4°C.
The supernatant typically contained 5 mg/ml of protein as determined by Bradford assay.
100 μM S-nitrosoglutathione (GSNO) or reduced glutathione (GSH) was added to 250 μl of the
total rat brain protein supernatant to make the final concentration of 1 μM of the glutathione
derivative in each sample. The reaction mixtures were incubated at 25°C for 20 min. Residual
GSNO or GSH were removed by acetone precipitation of proteins. Biotin Switch Technique, as
described previously by Jaffrey et al., was used to selectively substitute all S-nitrosylated cyste-
ines present in proteins by a biotin derivative [46]. Total protein fractions after BST were ana-
lyzed using reducing 15% Tricine-SDS-PAGE. Selectively biotinylated proteins were captured
using streptavidin-HRP conjugated antibodies and visualized using Amersham ECLWestern
Blotting Detection Reagent (GE Healthcare) with subsequent exposure to X-ray film. Further-
more, S-biotinylated proteins were enriched from the appropriate mixtures using neutravidin-
based affinity purification and resolved by reducing 15% Tricine-SDS-PAGE. Gel bands
observed in the low molecular weight region (from 6 kDa to 15 kDa) were excised and ana-
lyzed. Longer incubation time (16 hours) was used for in-gel tryptic cleavage of proteins taking
into account the resistance of S100B to enzymatic digestion [43]. The standard mass spectrom-
etry based protein identification protocol was optimized for the detection of the plausible
S100B protein. Measurements were carried using a Nano Aquity Liquid Chromatography sys-
tem (Waters, Milford, MA) coupled to LTQ-FTICR mass spectrometer (Thermo Scientific).
Mascot search engine (version 2.3, MatrixScience, Boston, MA) was used to survey data against
UniProtKB/Swiss-Prot database version 2011_07 (529056 sequences). Mascot search parame-
ters were set as follows: taxonomy—Rattus norvegicus, fixed modification—cysteine carbami-
domethylation, variable modification—methionine oxidation, parent ion mass tolerance–
30 ppm, fragment ion mass tolerance—0.1 Da, number of missed cleavages—1, enzyme speci-
ficity—semi-trypsin.
Enrichment of endogenously S-nitrosylated proteins using Biotin Switch
Technique (BST)
Confluent rat C6 glioma cells resuspended in 250 mMHEPES buffer, pH 7.7 with 1 mM
EDTA and 0.1 mM neocuproine (HEN buffer) and homogenized. Total protein concentration
of the lysate was adjusted to 1 mg/ml. Obtained cell lysates were treated using BST as previ-
ously described [37, 44]. Supernatants from each BST step were collected, proteins were sepa-
rated using 15% SDS–PAGE and transferred onto PVDF membrane (0.22 μm). After blocking
with non-fat dried milk, the PVDF membrane was incubated with goat anti-S100B polyclonal
antibody (1:1000 dilution, Santa Cruz Biotechnology) for 1 hour and afterwards for 1 hour
with peroxidase-conjugated rabbit anti-goat IgG (1:10000 dilution, Sigma-Aldrich). The
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peroxidase activity was visualized using the Amersham ECLWestern Blotting Detection
Reagent (GE Healthcare) with subsequent exposure to X-ray film.
Expression, purification and chemical S-nitrosylation of recombinant
S100B
S100BSH and S100BSNO proteins were obtained according to previously published methods
[43, 47]. All details specific for this study together with determination of S100B protein concen-
tration, using amino acid analysis and HPLC methods are presented in the S1 Text.
Zinc binding affinity analysis using a chromogenic chelator—4-(2-pyridylazo)
resorcinol (PAR)
Binding of zinc ions to either S100BSH or S100BSNO proteins was determined spectrophotomet-
rically using 4-(2-pyridylazo)resorcinol (PAR) assay [48]. The absorbance for ZnHxPAR2 com-
plex was determined at 500 nm using Cary UV-Visible spectrophotometer (Varian) with quartz
cuvettes of 1 cm path length. 10 μM S100BSH or S100BSNO proteins were titrated with 0–60 μM
ZnSO4 in presence of 64 μMPAR. Control titrations were performed for 64 μMPAR in different
experimental buffer. The absorption spectra were collected from 200 to 600 nm at 25°C. Experi-
ments were performed in Chelex1100-treated buffers as follows: 10 mM TES, pH 7.2, 15 mM
NaCl; 10 mM TES, pH 7.2, 10 mMCaCl2, 15 mMNaCl; and 10 mMTES, 150 mMNaCl, pH 7.2.
Relationship between the concentration of the zinc ion associated with the complex and the
absorbance at 500 nm served as a qualitative estimation of zinc affinity to S100B protein variants.
Isothermal Titration Calorimetry (ITC) experiments
For detailed preparation of buffers and protein solutions for ITC experiments see the S1 Text.
ITC measurements were carried out at 25°C using Microcal OMEGA ultrasensitive titration
calorimeter (MicroCal Inc.). Titration parameters (the number, volume and length of time of
injections) were set by the software program controlling data. Solutions in the cell were stirred
by a syringe at 400 rpm. The sample cell (1.3611 cm3) contained S100B protein solution, while
the reference cell contained only buffer. Upon equilibration, a calcium chloride solution pre-
pared in the same buffer as used in the sample cell, or zinc sulfate solution in pure water, was
injected in 40 x 4 μL aliquots using the default injection rate. 180 s intervals between each injec-
tion allowed the sample to return to baseline. When required, additional experiments were car-
ried out on nanoITC calorimeter (TA Instruments) using 62 injections of 4 μL to the 0.95 cm3
sample cell. Integrated heat effects of each injection were corrected by subtraction of the corre-
sponding integrated heat effects of CaCl2 (or ZnSO4) injection to the pure buffer and heat
effects of buffer injection to the protein solution.
Numerical methods used for ITC data analysis
Instead of iterative numerical models used in original Microcal/TA software provided by the
instrument producers, analytical models were used to fit experimental ITC data as described by
us previously [49, 50] and details in the S1 Text. Simplest binding models that reproduce
appropriate experimental data are shown in Table 1. Symbol 2s describes two sequential bind-
ing sites, 2i - two independent binding sites (which is equivalent to a single binding site of the
occupancy n = 2), 2i+2i, a combination of two sets of independent binding sites, that substan-
tially differ in their thermodynamic properties, each of occupancy equal 2, and 2s+2i a combi-
nation of two sequential binding sites with the third site (of occupancy equal 2) independent
from the previous two. In general, Zn-binding to “strong” (either 2s or 2i type) and “weak” (if
S-Nitrosylated Astrocytic S100B Protein
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detectable solely 2i) binding sites are independent. The thermodynamic parameters, together
with their standard errors, were estimated as the average values obtained from at least three
independent experiments (with the only exception of Ca2+-binding at high-salt conditions).
The putative stoichiometry for the Ca2+ binding by S100B-SH at high-salt was estimated using
the method originally proposed by Job [51].
Hydrogen-Deuterium Exchange Mass Spectrometry
Comparative hydrogen deuterium exchange mass spectrometry experiments were performed
for 100 μM solutions of recombinant S100BSH and S100BSNO proteins as described previ-
ously [52]. The peptides displaying decreased H/D exchange in S100BSNO are mapped on the
solution NMR structure of rat apo-S100B (PDB #1B4C) [53, 54].
Results
Identification of S100B protein as a potential S-nitrosylation target in rat
brain
Biotin switch technique is the mainstay experimental method to detect protein SNOs in com-
plex biological systems [46, 55]. BST is based on using ascorbate for selective reduction of the
protein SNOmoiety to a reduced thiol group (in the presence of other thiol modifications),
derivatization of the released thiol by a biotin derivative. Biotinylated protein fraction is enrich-
ment by affinity chromatography using neutravidin beads and further analyzed. In the pioneer
publication describing development of BST it has been shown that treating the whole brain
protein lysate with 1 μM or less nitric oxide donor leads to selective S-nitrosylation of some
brain proteins, that have been afterwards detected as S-nitrosylated in vivo [56]. Only proteins
of molecular mass higher than 20 kDa were analyzed. In this work we used analogous experi-
mental conditions to induce protein S-nitrosylation using GSNO but employed higher density
(>15%) SDS-PAGE gels to analyze the GSNO-treated brain lysate fraction enriched by BST
(S1 Fig). Using such procedure, routine for the detection of small S100 proteins, we have
observed proteins of low molecular mass that were not detected previously. Gel bands observed
in the low molecular weight region were excised, washed and digested with trypsin. Resulting
peptides were recovered by extraction and analyzed by mass spectrometry. S100B protein has
been clearly identified in the analyzed fractions. MS/MS fragmentation spectra for the Cys con-
taining S100B peptide are shown in S1 Fig.
Table 1. ITC-derived thermodynamic parameters for Ca2+ binding to S100BSH and S100BSNO protein monomers.
Protein site n Model Kas* ΔH (kcal/mol) TΔS (kcal/mol) ΔG (kcal/mol) ΔS (cal/mol/K)
S100BSH (low salt) Ca1 1 2s 0.3–8.9 104 2.5±0.8 8.3±1.0 -5.8±1.0 27.8±3.3
Ca1+Ca2 2 0.2–3.5 109 7.5±1.0 19.7±0.7 -12.2±0.9 66.1±2.4
Ca2 1 0.24–1.1 105 5.0±0.2 11.4±0.5 -6.5±0.4 38.3±1.6
S100BSNO (low salt) Ca1 1 2s 0.02–1.1 106 -0.3±1.6 6.8±2.5 -7.1±1.2 22.8±8.6
Ca1+Ca2 2 0.16–4.5 1010 2.5±0.7 16.1±0.6 -13.6±1.0 54.1±2.1
Ca2 1 0.31–1.1 105 2.8±1.6 9.3±1.9 -6.5±0.4 31.3±6.5
S100BSH (high salt) Ca1,2 2x 2i 0.9–2.6 104 1.2±0.3 7.0±0.4 -5.8±0.3 23±1.0
S100BSNO (high salt) Ca1 1 2s 0.4–1.1 104 0.1±0.3 5.4±0.4 -5.3±0.3 18±1.0
Ca1+Ca2 2 0.77–2.1 107 3.2±1.0 13.0±1.0 -9.8±0.3 44±4.0
Ca2 1 0.9–3.8 103 3.1±1.0 7.6±1.1 -4.5±0.4 25±4.0
* Range of values estimated from at least three independent experiments, [M-1] for Kas, [M
-2] for K1as K2as
X Stoichiometry assumed according to Job Plot (see S7 Fig)
doi:10.1371/journal.pone.0154822.t001
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S100B protein is endogenously S-nitrosylated in C6 glioma cells
We employed C6 glioma cells, a commonly used experimental model of astrocytes, to prove
the hypothesis that S100B protein may be endogenously S-nitrosylated inside cells. SNO pro-
teins from whole cell lysates of confluent, unstimulated C6 glioma cells were enriched using
optimized BST as described by us previously [37, 44]. Control experiments, in which ascorbate
reduction of SNO bonds was eliminated, were performed to identify proteins that nonspecifi-
cally bind to neutravidin resin. Recombinant S100BSNO protein was used as a positive control
of the BST efficiency in our hands. Protein fractions obtained at the end step of BST were ana-
lyzed by Western blotting by S100B recognizing antibody. As marked in Fig 1, S100B has been
detected in the positive control experiment (Fig 1, lane 1), the fraction enriched by a full BST
protocol that included ascorbate reduction (Fig 1, lane 6), and is not observed in the negative
control samples (Fig 1, lane 11). Such result unambiguously indicates that S-nitrosylation is an
intracellular modification of S100B protein.
Synthesis and initial characterization of unmodified and S-nitrosylated
recombinant human S100B protein
In order to gain insight into the consequences of S-nitrosylation on intrinsic properties of
S100B, both unmodified and S-nitrosylated recombinant human S100B forms have been
obtained and purified to homogeneity, as described by us previously [43] and in the S2 Fig.
Purity and correct masses of intact proteins were confirmed by analytical HPLC and mass
spectrometry, respectively (S3 and S4 Figs). Similarity of CD spectra profiles for both variants
suggested they both fold into similar structures (S5 Fig). Size exclusion chromatography pro-
files show that under all experimental conditions used in this work both S100B protein variants
were stable homodimers (S6 Fig).
Calcium affinity of S100B protein is increased by SNO both under high
and low ionic strength conditions
Ca2+ ion binding is a prerequisite for interaction of S100B protein with many biological targets.
In order to detect if S-nitrosylation attenuates Ca2+ affinity to S100B protein we used
Fig 1. S100B protein is S-nitrosylated in non-stimulated C6 glioma cells. The presence of S100B in protein fractions collected
from each step of BST was determined byWestern blotting. Chemically S-nitrosylated, recombinant human S100BSNO protein
eluted from neutravidin resin after BST enrichment, a positive control of BST (lane 1); total C6 glioma lysate before BST (lane 2),
fully derivatized protein fraction before affinity enrichment on neutravidin resin (lane 3); protein fraction unbound to neutravidin (lane
4); resin wash fraction (lane 5); proteins enriched on neutravidin resins (lane 6); total C6 glioma protein lysate before BST (lane 7);
total protein fraction before affinity enrichment on neutravidin resin (lane 8); protein fraction unbound to neutravidin (lane 9); wash
fraction (lane 10); proteins nonspecifically enriched on neutravidin resins, negative control of BST (lane 11). Lanes 1–6 depict BST
with ascorbate reduction and lanes 7–11without ascorbate reduction step. A clear difference in the presence of S100B band in the
protein fraction enriched on neutravidin beads after BST procedure with (lane 6) and without (lane 11) ascorbic acid is marked by
rectangles.
doi:10.1371/journal.pone.0154822.g001
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homogenous solutions of recombinant S100BSH and its S100BSNO counterpart and per-
formed comparative isothermal titration calorimetry (ITC) analysis of Ca2+ binding to these
proteins. ITC experiments were performed under two experimental conditions in TES buffer,
pH 7.2, with either low (15 mM) or high (150 mM) NaCl concentration at 25°C. The integrated
heat flow of individual injections (binding isothermograms) for representative CaCl2 titration
of S100BSH and S100BSNO at low (Fig 2A) and high (Fig 2B) ionic strength are presented in
Fig 2 as a function of the Ca2+ to protein monomer molar ratio.
Presented data reveal that under all measured conditions Ca2+-binding is an endothermic,
entropy driven process for both variants of S100B. The shape of all obtained Ca2+ binding
curves are similar except for unmodified S100B protein under higher ionic strength conditions.
Although, the exponential decay observed in the latter curve could suggest that only a single
Ca2+ is bound by the protein, a Job Plot analysis of data (S7 Fig) supports a 2:1 stoichiometry
for Ca2+/S100BSH binding. Consequently, approximately four Ca2+ ions are coordinated by an
S100B dimer (two per monomer) in all cases, regardless the salt concentration and the presence
of S-nitrosylation. Under low salt conditions, the unfavorable total heat effect accompanying
Ca2+ binding is nearly 3 times lower for S100BSNO than for S100BSH, strongly facilitating
Ca2+ binding. Table 1 shows calculated thermodynamic parameters for Ca2+ binding to the
investigated S100B forms. The binding isotherms were fit using a model of either sequential or
independent binding of two cations per monomer (2s or 2i in Table 1).
Average association constants for Ca2+-binding obtained by us for unmodified S100BSH in
low salt are in close agreement with data previously published by others (3.6 104 M-1 and 55.6
104 M-1, for S100BSH EF-hand 1 and EF-hand 2 motif, respectively) [19, 57]. Under our exper-
imental conditions, the SNO modification in S100BSNO strengthens the overall binding of
Ca2+ cations to the protein by an order of magnitude from a measured range of KCa1+Ca2 from
Fig 2. Representative integrated heat plots obtained for ITC titrations of Ca2+ ions to S100BSH (yellow
diamonds) and S100BSNO (blue diamonds) protein solutions in TES buffer, pH 7.2 at 25°C containing either
15 mM (A) or 150 mM (B) NaCl. The lines following data points represent best-fitted models described in
Table 1.
doi:10.1371/journal.pone.0154822.g002
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0.2–3.5 109 M-2 to 0.16–4.5 1010 M-2. As indicated by a different shape of the initial part of the
binding isotherm this change is mainly due to a significant increase of the firstly bound Ca2+
affinity, while binding of the second Ca2+ ion is virtually unaffected. The significant increase of
Ca2+ affinity of the first EF-hand of S100BSNO results both from favorable enthalpy and
entropy changes (TΔΔSSNOCa1 = 1.5 kcal/mol and ΔΔHSNOCa1 = -2.8 kcal/mol), whereas the
binding of the succeeding ion is almost unaltered due to a compensation of the SNO-related
enthalpy and entropy changes (TΔΔSSNOCa2 = -2.1 kcal/mol, ΔΔHSNOCa2 = -2.2 kcal/mol).
Consistent with previously published data [58] presence of a monovalent Na+ cation in the
protein solutions lead to a three orders of magnitude decrease of Ca2+ binding affinity for
S100B in comparison to low salt conditions (Table 1). Interestingly, ITC data clearly indicate
that higher concentration of Na+ makes binding of the two Ca2+ ions to an S100BSH monomer
completely independent. This suggests no interaction between the two EF-hand binding sites.
Such effect is not observed when Cys84 of S100B is S-nitrosylated.
S-nitrosylation is important in multifactorial regulation of Zn2+ binding to
S100B
Despite Ca2+-based modulation, the activity of S100B protein may be regulated in vivo by Zn2+
binding. To analyze the effect of S-nitrosylation on Zn2+ affinities to S100B, we initially per-
formed a competition assay with a chromogenic Zn2+ ion chelator 4-(2-pyridylazo)resorcinol
(PAR). Fig 3 shows the absorbance of the formed ZnHxPAR2 complex detected at 500 nm for
64 μM PAR chelator itself, a mixture of 64 μM PAR and 10 μM S100BSH protein, and a mix-
ture of 64 μM PAR and 10 μM S100BSNO, as a function of total Zn2+ in three different solu-
tions (TES buffer, pH 7.2 containing either CaCl2 (A) or 15 mMNaCl (B), or 150 mMNaCl
(C)).
As recently presented by Kocyła et al. [59] the use of PAR for indirect studies of zinc binding
to metalloproteins is not straightforward and strictly relies on proper knowledge of the formed
ZnHxPAR2 complex stability, its molar absorption coefficient and the stoichiometry of the
Zn2+-metalloprotein interaction, all of which may depend on the content of experimental buff-
ers. Thus, in this work we have compared only spectrophotometric data obtained in buffers of
the same composition. Decreased absorbance of the ZnHxPAR2 chromophore in the presence
of S100B variants indicates Zn2+ binding to the proteins. Under all of the conditions Zn2+ affin-
ity was higher for S100BSNO than for S100BSH.
Direct ITC titration experiments, similar to described above for Ca2+ binding studies, were
used to obtain precise numerical values of the Zn2+ to S100B affinity constants. The influence
of SNO and Ca2+-loading on Zn2+-binding to S100B was investigated. To achieve the goal,
comparative titrations were performed for both S100BSH and S100BSNO under several experi-
mental settings including the apo proteins under low and high salt conditions (15 mM or 150
mMNaCl, respectively), and for the fully Ca2+ loaded (holo) variants. Fig 4A–4C show repre-
sentative experimental Zn2+-binding isotherms obtained in our study. Usually three experi-
ments were performed for a different combination of S100B variant and buffer composition.
Zn2+ salt concentration in the titrant was varied if necessary to obtain high precision data
points in different parts of the binding curves. All of the binding isothermograms obtained in
this study are collected in S8 Fig.
As can be clearly observed in Fig 4, the isothermograms differed qualitatively from each
other depending on the presence of SNO, the loading of S100B with Ca2+, as well as the NaCl
concentration in the buffer. The most striking observed difference is the change from strongly
exothermic Zn2+ binding by the Ca2+ -loaded proteins to endothermic reactions for the Ca2+-
free S100B forms. Irrespective of ionic strength conditions, noncovalent dimers of both Ca2+-
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loaded (holo) S100BSH and S100BSNO proteins strongly bind two Zn2+ ions independently
(model 2i in Table 2). However, two additional, weaker binding independent sites can be iden-
tified for S100BSNO (model 2i+2i). The Zn2+ binding parameters for unmodified holo
Fig 3. Titration curves of PAR alone (diamonds) and in presence of either S100BSH (squares) or
S100BSNO (triangles) proteins with ZnSO4 measured in absorbance at 500 nm at 25°C. Experiments
were performed at (A) 10 mM TES buffer, pH 7.2, 10 mM CaCl2, 15 mM NaCl; (B) 10 mM TES buffer, pH 7.2,
15 mM NaCl and (C) 10 mM TES buffer, pH 7.2, 150 mMNaCl.
doi:10.1371/journal.pone.0154822.g003
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Fig 4. Representative integrated heat plots obtained for ITC titrations of Zn2+ ions to S100BSH (yellow diamonds) and
S100BSNO (blue diamonds) protein solutions. (A) Integrated heat plots for holo Ca2+-S100BSH and holo Ca2+-S100BSNO
protein with ZnSO4 in 10 mM TES buffer, pH 7.2, 15 mM NaCl. (B) Integrated heat plots for apo S100BSH and apo S100BSNO
protein with ZnSO4 in 10 mM TES buffer, pH 7.2, 15 mM NaCl. (C) Integrated heat plots for apo S100BSH and apo S100BSNO
protein with ZnSO4 in 10 mM TES buffer, pH 7.2, 150 mMNaCl.
doi:10.1371/journal.pone.0154822.g004
Table 2. ITC-derived thermodynamic parameters for Zn2+ binding to S100BSH and S100BSNO protein dimer.
Protein site n Model Kas* ΔH(kcal/mol) TΔS(kcal/mol) ΔG(kcal/mol) ΔS(cal/mol/K)
holo S100BSH Zn1,2 2 2i 1.3–5.3 106 -9.0±1.0 -0.2±0.5 -8.8±0.4 -1.0±2.0
holo S100BSNO Zn1,2 2 2i+2i 3.5–9.2 107 -9.2±1.2 1.5±1.4 -10.6±0.3 4.9±4.6
Zn3,4 2 0.3–3.1 105 -3.3±1.4 3.5±2.0 -6.80±0.7 11.7±6.8
apo S100BSH(low salt) Zn1 1 2s 2.3–3.4 106 0.7±1.0 9.5±1.0 -8.8±0.1 32±3.4
Zn1+Zn2 2 3.5–5.6 1012 10.2±0.9 27.6±0.7 -17.4±0.1 93±2.5
Zn2 1 1.4–1.8 106 9.6±1.6 18.1±1.6 -8.5±0.1 61±5.3
apo S100BSNO(low salt) Zn1 1 2s+2i nd nd nd nd nd
Zn1+Zn2 2 0.6–7.6 1013 -1.4±0.7 16.9±0.1 -18.3±0.8 56.7±0.3
Zn2 1 nd nd nd nd nd
Zn3,4 2 0.4–1.7 105 -6.1±1.6 0.7±2.1 -6.7±0.4 2.3±6.9
apo S100BSH(high salt) Zn1 1 2s+2i 1.6–2.5 107 3.5±1.0 13.5±1.1 -10.0±0.1 45±4.0
Zn1+Zn2 2 2.0–4.9 1013 11.9±0.5 30.4±0.3 -18.5±0.3 102±1.0
Zn2 1 1.0–2.8 106 8.3±1.3 16.9±1.2 -8.6±0.3 57±4.0
Zn3,4 2 0.8–2.8 105 -8.0±2.6 -0.9±3.0 -7.1±0.4 -3.0±10.0
apo S100BSNO(high salt) Zn1 1 2s+2i nd nd nd nd nd
Zn1+Zn2 2 0.9–1.4 1013 2.1±7.0 20.0±7.0 -17.9±0.1 67±23.0
Zn2 1 nd nd nd nd nd
Zn3,4 2 0.3–1.6 105 -6.8±3.2 -0.2±3.7 -6.6±0.5 -0.7±13.0
* Range of values estimated from at least three independent experiments, [M-1] for Kas, [M
-2] for K1as K2as
nd–not determined
doi:10.1371/journal.pone.0154822.t002
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S100BSH (KSHCa,Zn = 1.3–5.3 10
6 M-1) are close to data published previously (1.06 ± 0.18 107
M-1) [22]. Interestingly, holo S100BSNO binds Zn2+ more than 30 folds stronger than
S100BSH with KSNOCa,Zn in the range of 3.5–9.2 10
7 M-1. This is clearly evidenced in Fig 4A by
a much sharper transition observed at [Zn2+] to [S100B] ratio of 2. For both Ca2+-loaded pro-
teins, Zn2+ binding is mostly exothermic with a very low entropic contribution (ΔSSNOCa,Zn, see
Table 2). The additional, approximately three orders of magnitude weaker binding sites
detected solely for holo S100BSNO are entropy driven. Tightening of Zn2+-binding for holo
S100B due to SNO of Cys84 thiol is opposite to its decrease observed previously after thiol side
chain removal by a Cys84Ala mutation of S100B [22].
Zn2+ binding to metal-free (apo) S100B has not yet been studied by ITC. Zinc salt—induced
S100B oligomerization and precipitation has been suggested previously [22]. Based on our
experimental experience we have assumed that protein precipitation may be due to incremen-
tal amounts of Zn(OH)2 precipitates in buffered solutions of ZnSO4. The differences between
heat effects of injecting aqueous and buffered ZnSO4 solutions to the proteins was insignificant.
Indeed, if pure aqueous solutions of ZnSO4 were used for ITC titrations we were able to suc-
cessfully obtain Zn2+ binding isothermograms for Ca2+-free (apo) S100BSH and S100BSNO in
the presence of low (15 mM) and high (150 mM) NaCl concentrations in the buffer (presented
in Fig 4B and 4C, respectively). Substantial differences in the shape of measured isotherms
have been related both to changes in the ionic strength of the buffer and to the presence or
absence of the SNO modification. In contrast to data presented above for holo proteins, the
titration curves for apo S100B forms are not monotonic, but show one, for S100B in low salt
(15 mM NaCl), or even two inflection points, clearly identifying a contribution from two or
three types of binding sites, respectively. The experimental data were best reproduced with a
model that assumed two, unequivalent, sequential Zn2+ binding sites per an S100B dimer, pos-
sibly accompanied by two weaker ones, which are independent both from the first two, and
from each other (model 2s+2i, Table 2). This qualitatively differs from the observations made
for holo forms of S100BSH and S100BSNO, in which the independent binding of the two first
Zn2+ cations was observed (models either 2i or 2i+2i in Table 2). Thus, in the absence of Ca2+,
the Zn2+ sites in S100B interact with each other, leading to the sequential, highly cooperative
binding of the ions. As shown in Table 2, S-nitrosylation of Ca2+-loaded S100B leads to a gain
in the free energy of binding of the first two Zn2+ cations. A similar, but slightly lower effect, is
also observed for apo protein in low salt conditions, although not as pronounced as for the
Ca2+- loaded S100B.
In conclusion, the ITC-derived data reveal that the unmodified S100B exists as an equilib-
rium of Zn2+-free, single Zn2+ (dominating form) and doubly Zn2+-loaded protein popula-
tions, while only the apo and doubly Zn2+-loaded populations exist for S100BSNO, due to
highly cooperative binding of the two strongly bound Zn2+ ions. This cooperativity is even
stronger at higher ionic strength of the buffer (150 mMNaCl). Thus, in a buffer expected to
more closely resemble the physiological conditions, posttranslational SNO allows for a more
efficient Zn2+-dependent regulation of S100B already at moderate Zn2+ concentration.
Mass spectrometry monitored hydrogen/deuterium exchange used to
analyze SNO-induced effects in S100B protein
Rates of proton/deuterium (H/D) exchange of amide protons in S100BSH and S100BSNO pro-
teins were measured by mass spectrometry under identical experimental conditions, in which
the integrity and stability of the protein homodimers remained similar (data not shown). Aver-
age changes of masses related to different rates of deuterium incorporation were measured for
peptic fragments of both S100B variants. They were minimal for most fragments except for
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two peptides: Val80-Glu86 and Leu35-Phe43 for which the HD exchange was significantly
slower in S100BSNO than in S100BSH (presented in Table 3). Higher protection of amide
hydrogens in these regions of S100BSNO suggests an SNO-induced formation of a population
of more stiffened, hydrogen bonded structures directly in the vicinity of S-nitrosylation
(Cys84) and in the linker loop that connects the two EF-hand type calcium binding domains in
S100B protein. Though linker region is far in the protein sequence from the modification site,
it is proximal in space to Cys84 and may be affected by the presence of the SNO group. Fig 5A
shows the protein fragments of SNO-induced reduced flexibility marked on the NMR structure
of a rat S100B protein.
Discussion
S100 family proteins are multifunctional molecules with regulatory roles in a variety of physio-
logical and pathological processes. This lead to a long discussed question of how the individual
family members are regulated to play specific biological roles. The biological activity of S100
proteins is mainly achieved through target binding, often in a metal ion—dependent way in
response to increased Ca2+- or Zn2+- ion levels. Knowledge on other regulatory mechanisms of
S100 activities, including posttranslational modifications is still very limited. Most of the
known S100 proteins, except S100A12, S100A13 and calbindin have cysteine residues in their
primary sequence (Fig 5B). Redox modifications of cysteine thiols, in particular posttransla-
tional S-nitrosylation has been shown important in neutrophil S100 proteins, S100A8 and
S100A9. S-nitrosylation of S100A8 has been revealed to regulate inflammatory processes [60,
61]. Recently, it has been detected that upon inflammatory stimulus of a mixture of interferon
gamma and oxidatively-modified low-density lipoprotein a heterodimer of S100A8 and
S100A9 plays a crucial role in an S-nitrosylase complex with the inducible form of nitric oxide
synthase (iNOS) [62]. The presence of both S100A8 and S100A9 is responsible for selectivity of
the complex, while a cysteine of S100A9 is S-nitrosylated by iNOS and transfers the NO group
to cysteines in selected protein targets i.e. GAPDH [62]. Endogenous S-nitrosylation of another
S100 protein family member, the cardiac and brain S100A1, has been detected in PC12 cells
[44].
In this work we experimentally revealed that a cysteine thiol in S100B protein is one of the
targets of S-nitrosoglutathione induced S-nitrosylation in whole rat brain lysate. This is similar
to several other proteins identified in a similar experimental setting previously by Jaffrey et al.
(58). Most of these proteins were later identified to be important nitrosylation targets in vivo
[56]. Furthermore, we detected S-nitrosylation as an endogenous PTM of S100B protein in C6
glioma cells—a frequently used experimental model of astrocytes. This is only the second iden-
tified to date PTM of S100B. The presence of S100BSNO inside cells motivated us to study the
molecular mechanism by which S-nitrosylation may differentiate the activity of S100B protein.
It is not fully understood how post translational S-nitrosylation exerts its effects in proteins.
The simplest identified mechanism is direct chemical protection of a cysteine thiol. This way
SNO derivatization of active site thiols alters the activity of enzymes such as dimethylarginine
Table 3. H/D exchange results for S100BSH and S100BSNO as assessed by liquid chromatography combined with mass spectrometry (LC-MS).
Residue number Peptide sequence m/z (charge) Mass [Da] H/D exchange (mass shift)
after 10 min
H/D exchange (mass shift)
after 30 min
S100BSH S100BSNO S100BSH S100BSNO
35–43 LINNELSHF 543.8(2) 1085.6 5.16±0.28 4.52±0.22 5.84±0.17 4.80±0.18
80–86 VTTACHE 760.5(1) 759.5 5.88±0.31 4.50±0.13 7.20±0.13 5.13±0.14
doi:10.1371/journal.pone.0154822.t003
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dimethylaminohydrolase [63]. However, no Cys-dependent enzymatic activity has been
assigned to S100B. Under other circumstances, reversible formation of SNO has been shown to
temporarily shield reactive protein thiols from irreversible oxidation under oxidative stress
[64] or on the contrary activate the thiol toward formation of further post-translational modifi-
cations like sulphenic or sulphonic acid as for human glutathione reductase [65]. Information
on the structural consequences of SNO adduct formation in proteins is very limited. There are
only 14 X-ray structures of SNO modified proteins deposited in the PDB database for 8 unique
proteins due to difficulties in obtaining homogenous, selectively S-nitrosylated proteins in suf-
ficient amounts for structural studies and the lability of SNO bond because of its sensitivity to
radiation. In most of the solved structures replacement of a cysteine free thiol by the SNO
Fig 5. (A) Peptides displaying decreased H/D exchange in S100BSNOmapped on a NMR solution structure
of rat apo-S100B protein (PDB #1B4C). One of S100B protein monomers is marked in grey, cysteine 84 side
chains are marked in green. Peptide fragments Val80-Glu86 and Leu35-Phe43 are marked in magenta and
navy, respectively. (B) Sequence alignment of human S100 proteins. Conserved carboxyterminal Cys
residues are highlighted in red. Residues responsible for Ca2+ coordination in the EF-hand loops are marked
light grey.
doi:10.1371/journal.pone.0154822.g005
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group does not lead to conformational changes other than accommodation of the NO group
close to the site of modification. However, in thioredoxin 1 the SNO of Cys62 results in a sig-
nificant helix rotation and structure disordering [66], while in protein tyrosine phosphatase
PTP1B the SNO of Cys215 leads to a reorganization of hydrogen bond network [64]. This indi-
cated a role for allosteric mechanisms in the SNO-related control of protein function. Compar-
ison of structural NMR data for unmodified S100A1 and S100A1SNO, performed by us
previously, found that the Cys85 thiol side chain forms a thiol/aromatic molecular switch
which upon S-nitrosylation changes the conformation of S100A1. Another effect of S100A1 S-
nitrosylation was an increased calcium affinity of the protein.
Data presented in this work provide detailed information on the consequences of S-nitrosy-
lation and the unique flexibility of human S100B protein in changing its modes of binding and
affinities toward Ca2+ and Zn2+ ions under different conditions. Various experimental tech-
niques have been used by others to reveal metal-binding properties of S100 proteins including
S100B [57, 67, 68]. In our work we initially tried to use optical spectroscopic techniques to
study the influence of posttranslational SNO on metal ion binding to S100B. Unfortunately,
neither UV-vis (data not shown) or CD spectra differentiated significantly the Ca2+ bound and
free forms of S100BSH and S100BSNO. Other commonly used methods of measuring metal
ion to protein binding are competition assays with relatively cheap chromogenic chelators of
appropriate ions. To obtain reliable results using such methods an optimal chelator should not
interact with the protein, has to have well defined stoichiometries of the formed metal ion com-
plexes, and metal ion affinities close to the proteins studied [59, 69]. As the Ca2+ affinities of
S100B are known to differ over three orders of magnitude under the low and high ionic
strength conditions used in this work we did not attempt to use the chelator studies in this
case. However, using the water soluble Zn2+ chelator—4-(2-pyridilazo) resorcinol (PAR) we
initially revealed that S-nitrosylation significantly increases Zn2+ affinity of S100B protein.
Isothermal titration calorimetry has been used previously to study both metal ion binding
to S100 proteins and their mutants [22]. ITC is particularly well suited to study the thermody-
namic consequences of PTMs of proteins [70, 71]. Its superiority over other methods is that
ITC experiments are performed in solution, do not require additional protein labeling, and
directly provide thermodynamic data concerning the stoichiometry (n), association constants
(Kas) and changes of standard molar enthalpy (ΔH). Thus, we used ITC as a direct method to
compare the Ca2+ and Zn2+ binding to S100BSH and S100BSNO in further detail. ITC-derived
data presented herein provide a multitude of different information. Detailed information on
the thermodynamic parameters of binding, including in most cases both cumulative binding
constants and the binding affinities of individual ions has been obtained. Presented data con-
firm the large decrease in Ca2+ affinity for S100B protein in buffers that contain 150 mMNaCl
relative to low salt buffers. Since the binding of the two Ca2+ ions to unmodified S100B under
high ionic strength conditions is totally independent the possible molecular mechanism of
such a decrease is the lack of contact between the Ca2+ binding sites in S100B. Interaction of
pairs of EF-hand sites has been proven important for efficient ion binding in many EF-hand
type proteins [72]. Presented data indicate that S-nitrosylation significantly tightens Ca2+ bind-
ing to S100B under all conditions studied and thus if present under native conditions could
lead to a greater proportion of Ca2+-loaded protein capable of interacting with its targets.
In addition to Ca2+—binding modulation, SNO of Cys84 significantly increases the Zn2+-
affinity of S100B (up to two orders of magnitude for the Ca2+-loaded form) under various
experimental conditions. Calculated binding constants and thermodynamic parameters indi-
cate a significant change in the mode of Zn2+ binding for the Ca2+-loaded S100B, which is not
identical in unmodified and S-nitrosylated S100B forms. While interrelation of Ca2+ and Zn2+
binding has been previously described for unmodified S100B and other S100 proteins, which
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are known to bind both of these ions [22, 67, 73], this work adds the new information on mod-
ulation of this cross-talk by posttranslational S-nitrosylation of S100B.
Until now, a connection of S-nitrosylation and Zn2+-binding has been only described for
proteins in which Zn2+ is directly coordinated by cysteine thiol ligands, like metallothionein or
zinc finger domains. SNO of the coordinating thiols impairs Zn2+ binding and leads to release
of the ion or strong weakening of its binding [74]. To the best of our knowledge, S100B is the
first example of a protein in which regulation of Zn2+-binding may be directly connected to a
reversible PTM of a non-coordinating cysteine residue. Our data suggest that nitrosylation of
proteins may serve as an NO-dependent, reversible molecular mechanism of transferring of
the Zn2+ ion from strong protein binders, with thiols in the primary Zn2+ coordination sphere,
which are significantly weakened by thiol SNO, to weaker binders with SNO-induced,
increased Zn2+ affinity, such as S100B protein, which coordinate Zn2+ by a combination of His
and Glu side chains and may be present in vivo in very high concentrations.
Previous studies described the use of engineered mutants of S100 proteins to find a relation-
ship between protein sequence, structure and ion binding in this class of proteins. For some of
the mutant proteins, structural perturbations were observed far from the site of mutation. This
lead to a hypothesis that the four-helix EF-hand domains is as a single globally cooperative
unit regulated by some key residues that are crucial for the protein's fold and function [75].
HD exchange experiments presented in this work indicate that SNO of Cys84 induces confor-
mational rearrangements in S100B at two sites in the protein sequence, the linker region and
the C-terminal helix, both important for S100Bs interaction with biological targets. This sug-
gests that Cys84 is one of the key regulatory residues in the EF-hand type S100B protein. Simi-
lar results have been previously obtained for the S100A1 protein dimer by classical structure
elucidation studies using NMR spectroscopy.
In conclusion, based on our in vitro studies, it is tempting to propose that formation of
endogenous SNO of S100B protein could be one of the in vivomechanisms that, through regu-
lation of the proteins affinity to metal ions, and modulation of protein conformation at struc-
tural elements that are crucial for target binding, could be responsible for the functional
diversity of the protein.
Further in vivo research is necessary to prove the role of S-nitrosylation of S100B i.e. under
conditions when nitrosative stress accompanies a very high overexpression of S100B protein as
observed in brain pathologies like Down Syndrome or Alzheimer’s disease and also in other
cell types and other pathologies. For example, NO synthase activity is strongly up-regulated in
melanoma cell lines, while the concentration of S100B in melanocytic tumor is roughly 100
times higher than in normal skin [76]. If confirmed, the endogenous formation of S100BSNO
in melanoma cells would have be taken under consideration in the on-going drug discovery
process for melanoma treatment based on small molecule inhibitors directly targeting S100B
[2].
Supporting Information
S1 Fig. Detection of protein S-nitrosylation in a brain lysate. Brain lysates were treated with
NO donor GSNO analyzed using BST. Modified proteins were enriched using neutravidin
resin and analyzed using tricine-SDS-PAGE. Excised from the gel protein bands followed by
trypsin digestion were measured using Nano Aquity Liquid Chromatography system (Waters)
coupled to LTQ-FTICR mass spectrometer (Thermo Scientific). (A) Western blot analysis of
biotinylated proteins in GSH- (lane 1) and GSNO-treated (lane 2) brain lysate. Proteins after
BST were resolved by tricine-SDS-PAGE, transferred to PVDF membranes, and detected using
anti-biotin antibody. (B) Tricine-SDS-PAGE gel of SNO proteins after BST, enriched using
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neutravidin resin in GSH- (lane 1) and GSNO-treated (lane 2) brain lysate. (C) Annotated MS/
MS-derived sequence of S100B peptide.
(PDF)
S2 Fig. Preparative purification of recombinant S100B protein variants. (A) Representative
preparative chromatograms obtained for isolation of S100BSH protein from E. coli bacterial
culture by semi-preparative HPLC (C18 column, 45 to 65% mobile phase (0.1% TFA in
acetonitrile (v/v) in 60 min; flow rate: 2 mL/min). The protein elution was detected by UV
simultaneously at two different wavelengths either 220 and 280 nm. (B) Representative chro-
matograms obtained for S-nitrosylated S100B protein by semi-preparative HPLC (C18 column,
50 to 58% mobile phase (0.1% TFA in acetonitrile (v/v) in 40 min; flow rate: 2 mL/min). The
protein elution was detected by UV simultaneously at two different wavelengths either 220 and
334 nm.
(PDF)
S3 Fig. Representative analytical chromatograms of S100BSH and S100BNO proteins after
dialysis prior the ITC runs. The reversed-phase gradient for analysis was from 50 to 64%
mobile phase (0.1% TFA in acetonitrile (v/v)) in 14 min; flow rate: 1 mL/min. The protein elu-
tion was detected by UV simultaneously at two different wavelengths either 220 and 280 nm
for S100BSH (A) or 220 nm and 334 nm for S100BSNO (B).
(PDF)
S4 Fig. Mass spectrometry analysis of S100B proteins. ESI mass spectrum before (A, B) and
after deconvolution (C, D) for S100BSH (left panel) and S100BNO (right panel) proteins using
Q-TOF Premier mass spectrometer.
(PDF)
S5 Fig. Far UV CD spectra of the apo (A) and holo (B) S100BSH (black solid line) and
S100BSNO (blue dash line) proteins. CD spectra were collected using Aviv Circular Dichro-
ism Spectrometer Model 202, with quartz cuvettes of 0.1 cm path length at 25°C. Measurement
was performed for each protein at 10 μM concentration in 10 mM TES buffer, pH 7.2, an aver-
age of three scans was recorded scanning from 198 nm to 250 nm.
(PDF)
S6 Fig. Oligomeric state of S100BSH and S100BSNO in solution determined by size exclu-
sion chromatography. Proteins were analyzed before (black lines) and after (red lines) every
ITC run. 200 μl of 100 μM protein solution was loaded onto Superdex 75 10/300 GL size exclu-
sion chromatography column (GE Healthcare) in appropriate buffers (as indicated at chro-
matograms A-H). Proteins were eluted as one oligomeric species corresponding to dimeric
form of S100B protein both for unmodified and SNO variants.
(PDF)
S7 Fig. Job plot for the Ca2+ binding to the S100BSH protein in high ionic strength buffer.
Job plot suggesting the binding stoichiometry for an Ca2+-S100BSH complex in 10 mM TES
buffer, pH 7.2, 150 mMNaCl.
(PDF)
S8 Fig. Ca2+ and Zn2+ binding to the recombinant S100B protein variants. All ITC data
(binding isothermograms) obtained for titration of: Ca2+ ions to S100BSH (A1-A7) and
S100BSNO (B1-B3) protein solutions in TES buffer, pH 7.2, 15 mMNaCl at 25°C; Ca2+ ions to
S100BSH (C1) and S100BSNO (D1) protein solutions in TES buffer, pH 7.2, 150 mMNaCl at
25°C; Zn2+ ions to S100BSH (E1-E3) and S100BSNO (F1-F3) protein solutions in TES buffer,
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pH 7.2, 15 mM NaCl at 25°C; Zn2+ ions to S100BSH (G1-G3) and S100BSNO (H1-H2) protein
solutions in TES buffer, pH 7.2, 150 mMNaCl at 25°C; Zn2+ ions to Ca2+-S100BSH (I1-I3) and
Ca2+-S100BSNO (J1-J3) protein solutions in TES buffer, pH 7.2, 15 mMNaCl at 25°C.
(PDF)
S1 Text. Materials and Methods.
(DOCX)
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